Nuclear medicine in oncology
نویسندگان
چکیده
منابع مشابه
Nuclear medicine in oncology
Oncological applications of nuclear medicine have entered a new era as a result of a greater understanding of the biological characteristics of tumours and the increasing availability of Positron Emission Tomography (PET). Fluorine-i8 labelled flurodeoxyglucose has been shown to be effective in differentiating malignant from benign tumours and in determining the extent of disease. New opportuni...
متن کاملNuclear medicine in pediatric oncology.
Pediatric malignancies are relatively rare and account for 0.5% of all cancers. The annual incidence varies between 110 and 150 per million children, which means that the chance for a child to develop a cancer during the first 15 years of life is 1:450–600. Leukemias and tumors of the brain and spinal cord have the highest relative incidence rates, followed in frequency by neuroblastoma, lympho...
متن کاملNuclear Medicine Series: Non-FDG PET Radiotracers in Oncology
F-18 NaF PET/CT has been shown to have higher sensitivity than planar 99m-Tc MDP bone scanning in several studies. The concomitant acquisition of anatomic images permits immediate correlation of any abnormal findings. Additionally, F-18 NaF PET/CT bone imaging can be quantitated, allowing bone disease to be 'measureable', increasing its utility therapy monitoring. When a consistent F-18 NaF upt...
متن کاملHistory and Perspectives of Nuclear Medicine in Myanmar
Nuclear Medicine was established in Myanmar in 1963 by Dr Soe Myint and International Atomic Energy expert Dr R. Hochel at Yangon General Hospital. Nuclear medicine diagnostic and therapeutic services started with Probe Scintillation Detector Systems and rectilinear scanner. In the early stage, many Nuclear Medicine specialists from the International Atomic Energy Agency (IAEA) spent some time ...
متن کاملClinical Medicine Reviews in Oncology
Although progress could have been achieved in treatment of patients with advanced non-small cell lung cancer (NSCLC), outcome still remains poor. One of the strategies to improve survival currently under investigation is maintenance therapy, e.g. prolongation of treatment duration with the administration of an agent at the end of a defined number of initial chemotherapy cycles. This can consist...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Radiotherapy in Practice
سال: 2000
ISSN: 1460-3969,1467-1131
DOI: 10.1017/s146039690000011x